French pharma company halts Covid-19 drug trial after 'inconclusive' clinical tests

  • 📰 thejournal_ie
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 50%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The drug was being developed to treat serious cases of the disease.

Sanofi is one of many companies developing a vaccine. Image: PA Sanofi is one of many companies developing a vaccine. Image: PA FRENCH PHARMA GIANT Sanofi has said that international Phase 3 clinical tests of its Kevzara drug for serious Covid-19 cases had proved inconclusive and it was halting the trial.

Sanofi said neither it nor its American partner in developing the drug, Regeneron, “envisage further clinical tests of Kevzara for the treatment of Covid-19.” Since the outbreak of the coronavirus pandemic late last year in China, it has claimed more than 800,000 lives and caused huge economic damage, sparking a global race to find a vaccine and effective treatments.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 32. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Covid-19 risks weighed against harm of closures - GlynnActing Chief Medical Officer Dr Ronan Glynn has written an open letter to parents and school staff, acknowledging their concerns as children return to classrooms across Ireland this week.
Source: rtenews - 🏆 1. / 99 Read more »